Thomas Collet's Location
Cambridge, MA, US
Thomas Collet's Work
- President and CEO @ Bilayer Therapeutics
- Principal (Life Science Consulting, Strategy to Implementation, Discovery to Commercialization) @ Collet Consulting LLC (CCLLC)
- Senior Partner @ CEPTON Strategies
- Visiting Scholar @ The Wyss Institute at Harvard University
- President and CEO and Co-Founder (rare disease and orphan drug, discovery to Phase 2, Duchenne MD) @ Phrixus Pharmaceuticals, Inc.
- Mentor In Residence @ University of Michigan, Office of Technology Transfer
- President and CEO and Co-Founder (Women's Health and endometriosis and uterine fibroids, repurposing) @ Meditrina Pharmaceuticals, Inc.
- President and CEO and Co-Founder (oncology, NHL, DNAi) @ ProNAi Therapeutics
- President and CEO and Co-Founder (neurovascular med device, hemorrhagic stoke, aneurisym, AVM, alginate) @ Neural Intervention Technologies, Inc.
- President and CEO (genomics tools, unbiased whole genome amplification, DNA sequencing, SNP scoring) @ Rubicon Genomics
Thomas Collet's Education
- Massachusetts Institute of Technology1985 - 1991
- RWTH Aachen University1983 - 1985
Thomas Collet's Skills
- French Passable Fluency
- Dual Citzen Usa Germany
- Business Development
- Marketing
- Arbor
- Business Analysis
- English Native Fluency
- Strategic Planning
- Native German Speaker
- Quality Management
Thomas Collet's Summary
Thomas Collet, based in Cambridge, MA, US, is currently a President and CEO at Bilayer Therapeutics, bringing experience from previous roles at Collet Consulting LLC (CCLLC), CEPTON Strategies, The Wyss Institute at Harvard University and Phrixus Pharmaceuticals, Inc.. Thomas Collet holds a 1985 - 1991 Massachusetts Institute of Technology. With a robust skill set that includes French Passable Fluency, Dual Citzen Usa Germany, Business Development, Marketing, Arbor and more, Thomas Collet contributes valuable insights to the industry. Thomas Collet has 6 emails and 1 mobile phone number on RocketReach.
5 free lookups per month.
No credit card required.
If you need more lookups,
subscriptions start at $48 USD/month.
Not the Thomas Collet you were looking for?
Find contact details for 700 million professionals.
Others Named Thomas Collet
-
11
-
2
-
11
-
1
People Like Thomas Collet
-
23
-
ViewLaura Sepp-Lorenzino
Chief Scientific Officer at Intellia Therapeutics, Inc.
Boston, Massachusetts, United States22 -
5+5+
-
35
-
3
-
54
-
55+
-
25+
-
View
Hugh Davis
Chief Operating Officer and President, Biosion USA, Inc. at Biosion, Inc.
West Chester, PA, US43 -
35+
-
35+
-
5+5
-
23
-
35+
-
View
Alexander Steiner
Vice President and Head of Business Development at Prellis Biologics
California, United States23 -
55+
-
21
-
35+
-
32
-
25+
Top Bilayer Therapeutics Employees
-
5+5+
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups / month.
Search
Search over 700
million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers
(business & personal).
G2Crowd Trusted
300K+
Plugin Users
